New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

about

Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.

P2860

Q47673940-C06C8BC2-F562-4F8B-A7D6-078BDEC3ABDF

P2860

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

Item

http://www.wikidata.org/entity/Q42331849

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@en

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@nl

type

Item

label

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@en

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@nl

prefLabel

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@en

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@nl

P1476

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

@en

P2093

Amel G Sengal

http://www.w3.org/2001/XMLSchema#string

Anne Moreau

http://www.w3.org/2001/XMLSchema#string

Carl E Allen

http://www.w3.org/2001/XMLSchema#string

Caroline Thomas

http://www.w3.org/2001/XMLSchema#string

Jean Donadieu

http://www.w3.org/2001/XMLSchema#string

Jean-François Emile

http://www.w3.org/2001/XMLSchema#string

Rikhia Chakraborty

http://www.w3.org/2001/XMLSchema#string

Sylvie Fraitag

http://www.w3.org/2001/XMLSchema#string

Sébastien Héritier

http://www.w3.org/2001/XMLSchema#string

Zofia Hélias-Rodzewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent BRAF mutations in Langerhans cell histiocytosis

RAF inhibitors that evade paradoxical MAPK pathway activation

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

P2888

s12943-017-0690-z

P304

115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12943-017-0690-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine Bellanné-Chantelot

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090388823

http://www.w3.org/2001/XMLSchema#string

P698

28679432

http://www.w3.org/2001/XMLSchema#string

P932

5498996

http://www.w3.org/2001/XMLSchema#string

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

about

P2860

P2860

New somatic BRAF splicing mutation in Langerhans cell histiocytosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932